keynote-224: second-line pembrolizumab for advanced hepatocellular carcinoma
Published 2 years ago • 123 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
3:02
keynote-224: second-line pembrolizumab’s value in hcc
-
2:25
current therapies for advanced hcc and their limitations
-
5:42
hepatocellular carcinoma: changes to clinical guidelines
-
4:30
new treatments for hepatobiliary cancers: hepatocellular carcinoma
-
1:44
global treatment pattern variations in hcc
-
2:19
the future of treatment in hepatocellular carcinoma
-
8:07
treatment approach in progressive hepatocellular carcinoma
-
59:11
understanding phenotypic plasticity in hepatocellular carcinoma to mitigate therapy resistance
-
7:11
disparities in surgical approach for hepatocellular carcinoma
-
7:42
dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma
-
6:53
hepatocellur carcinoma
-
3:45
evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with...
-
1:17
inhibiting dkk1 enhances sorafenib efficacy in hcc
-
1:08
case 2: cisplatin-ineligible metastatic bladder cancer
-
11:00
delivering guideline-based hepatocellular carcinoma care with an interactive tool
-
14:22
updates in hepatocellular carcinoma
-
6:42
selecting frontline multikinase inhibition in hcc
-
33:32
konsensus tatalaksana karsinoma hepatosellulare indonesia 2021
-
2:06
dr. choueiri on phase i/ii data of mk-6482 in advanced clear cell rcc